Publicacións en colaboración con investigadores/as de Hospital Clinic Barcelona (25)

2023

  1. ALERGODATA: Sentinel Registry of Health Outcomes in Allergic Patients Treated With Biological Therapies at Specialized Allergology Clinics in Spain

    Journal of Investigational Allergology and Clinical Immunology, Vol. 33, Núm. 6, pp. 479-482

2022

  1. Efficacy of subcutaneous house dust mite immunotherapy in patients with moderate to severe allergic rhinitis

    Immunotherapy, Vol. 14, Núm. 9, pp. 683-694

  2. Major Allergen Content in Allergen Immunotherapy Products: The Limited Value of Numbers

    Journal of Investigational Allergology and Clinical Immunology, Vol. 32, Núm. 5, pp. 345-356

2021

  1. Seaic specialty forum: Analysis of the current situation of allergology in spain and outlook for the future

    Journal of Investigational Allergology and Clinical Immunology, Vol. 31, Núm. 2, pp. 120-131

2019

  1. Changes in mammographic density over time and the risk of breast cancer: An observational cohort study

    Breast, Vol. 46, pp. 108-115

2018

  1. Safety and Quality Recommendations in Allergy Medicine (Spanish acronym, RESCAL)

    Journal of investigational allergology & clinical immunology, Vol. 28, pp. 1-39

2017

  1. A Genome-wide Association Study Identifies Risk Alleles in Plasminogen and P4HA2 Associated with Giant Cell Arteritis

    American Journal of Human Genetics, Vol. 100, Núm. 1, pp. 64-74

  2. Características clínicas al diagnóstico de una cohorte prospectiva de pacientes con lupus eritematoso sistémico atendidos en servicios de Medicina Interna españoles: estudio RELES

    Revista Clinica Espanola, Vol. 217, Núm. 1, pp. 7-14

  3. Clinical and epidemiological differences between men and women with systemic sclerosis: A study in a Spanish systemic sclerosis cohort and literature review

    Clinical and Experimental Rheumatology, Vol. 35, pp. S89-S97

  4. Differences Between Alcoholic and Nonalcoholic Patients With Wernicke Encephalopathy: A Multicenter Observational Study

    Mayo Clinic Proceedings, Vol. 92, Núm. 6, pp. 899-907

  5. The Clinical Course of Venous Thromboembolism May Differ According to Cancer Site

    American Journal of Medicine, Vol. 130, Núm. 3, pp. 337-347

2016

  1. Allergy immunotherapy across the life cycle to promote active and healthy ageing: From research to policies

    Clinical and Translational Allergy, Vol. 6, Núm. 1

  2. First month prednisone dose predicts prednisone burden during the following 11 months: An observational study from the RELES cohort

    Lupus Science and Medicine, Vol. 3, Núm. 1

  3. Patterns of drug therapy in newly diagnosed Spanish patients with systemic lupus erythematosus

    Clinical and Experimental Rheumatology, Vol. 34, Núm. 3, pp. 466-472

  4. Systemic activity and mortality in primary Sjögren syndrome: Predicting survival using the EULAR-SS Disease Activity Index (ESSDAI) in 1045 patients

    Annals of the Rheumatic Diseases, Vol. 75, Núm. 2, pp. 348-355

2014

  1. Diagnosis and allergen immunotherapy treatment of polysensitised patients with respiratory allergy in Spain: An Allergists' Consensus

    Clinical and Translational Allergy, Vol. 4, Núm. 1

  2. Systemic involvement in primary Sjögren's syndrome evaluated by the EULAR-SS disease activity index: Analysis of 921 spanish patients (GEAS-SS registry)

    Rheumatology (United Kingdom), Vol. 53, Núm. 2, pp. 321-331

2013

  1. Resistance to the most recent protease and non-nucleoside reverse transcriptase inhibitors across HIV-1 non-B subtypes

    Journal of Antimicrobial Chemotherapy, Vol. 68, Núm. 9, pp. 1994-2002

  2. Rilpivirine resistance mutations in HIV patients failing non-nucleoside reverse transcriptase inhibitor-based therapies

    AIDS, Vol. 27, Núm. 1, pp. 81-85

2012

  1. Clinical, virological and biochemical evidence supporting the association of HIV-1 reverse transcriptase polymorphism R284K and thymidine analogue resistance mutations M41L, L210W and T215Y in patients failing tenofovir/emtricitabine therapy

    Retrovirology, Vol. 9